SCHEMBL3025752

SCHEMBL3025752

CCOc1ccccc1CCO

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.60
L3MBTL1 Q9Y468 4/20 0.56
MAPT P10636 3/20 0.56
NPSR1 Q6W5P4 1/20 0.56
ATM Q13315 2/20 0.50
GAA P10253 2/20 0.50
MEN1 O00255 1/20 0.50
THRB P10828 1/20 0.50
RECQL P46063 1/20 0.50
BLM P54132 1/20 0.50
KMT2A Q03164 1/20 0.50
PLEC Q15149 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
GLA P06280 1/20 0.47
POLB P06746 1/20 0.46
MAPK1 P28482 1/20 0.45
KDM4E B2RXH2 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2B Q13224 1/20 0.43
HTR7 P34969 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9027053 0.89 ALDH1A1 (0.57) ALDH1A1L3MBTL1MAPTNPSR1ATM
SCHEMBL5661565 0.85 MAPT (0.49) ALDH1A1L3MBTL1MAPTNPSR1ATM
SCHEMBL30079604 0.83 L3MBTL1 (0.60) ALDH1A1L3MBTL1MAPTNPSR1ATM
SCHEMBL695757 0.83 L3MBTL1 (0.60) ALDH1A1L3MBTL1MAPTNPSR1ATM
SCHEMBL13875098 0.83 HTR1A (0.46) ALDH1A1TDP1HTR1ADRD2
SCHEMBL4262567 0.83 L3MBTL1 (0.60) ALDH1A1L3MBTL1MAPTNPSR1ATM
SCHEMBL7759613 0.83 CYP1A2 (0.53) ALDH1A1L3MBTL1MAPTNPSR1ATM
SCHEMBL24808599 0.82 MAPT (0.50) L3MBTL1MAPTNPSR1MEN1THRB
SCHEMBL4174956 0.82 ALDH1A1 (0.46) ALDH1A1L3MBTL1MAPTNPSR1ATM
SCHEMBL10335287 0.82 ALDH1A1 (0.48) ALDH1A1L3MBTL1MAPTNPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109970760-B ACC inhibitors and uses thereof 吉利德阿波罗公司 2022-04-26 CN disclosed
EP-3628320-B1 ACC INHIBITORS AND USES THEREOF GILEAD APOLLO LLC (US) 2022-03-16 EP disclosed
CN-112955421-A Method for dehydrating organic solvent and method for purifying organic solvent 日本瑞翁株式会社 2021-06-11 CN disclosed
CN-112189002-A Method for purifying solvent 日本瑞翁株式会社 2021-01-05 CN disclosed
CN-107532017-B Stripping solvent composition, stripping method and cleaning solvent composition 日本瑞翁株式会社 2020-11-06 CN disclosed
WO-2020195454-A1 METHOD FOR DEHYDRATING ORGANIC SOLVENT AND METHOD FOR PURIFYING ORGANIC SOLVENT 日本ゼオン株式会社 2020-10-01 WO disclosed
US-20200102323-A1 ACC INHIBITORS AND USES THEREOF SCHRÖDINGER, INC. 2020-04-02 US disclosed
US-20200102323-A1 ACC INHIBITORS AND USES THEREOF SCHRÖDINGER, INC. 2020-04-02 US disclosed
EP-3628320-A1 ACC INHIBITORS AND USES THEREOF Gilead Apollo, LLC (US) 2020-04-01 EP disclosed
WO-2020044825-A1 METHOD FOR SOLVENT PURIFICATION 日本ゼオン株式会社 2020-03-05 WO disclosed
WO-1995028640-A1 COMPLEX COMBINATORIAL CHEMICAL LIBRARIES ENCODED WITH TAGS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1995-10-26 WO disclosed
EP-0406745-B1 Antibiotic GE 2270 factors A1, A2, A3 and H LEPETIT SPA (IT) 1995-01-25 EP disclosed
US-5139778-A ANTIBIOTIC GE 2270 FACTORS A1, A2, A3 AND H GRUPPO LEPETIT SPA (IT) 1992-08-18 US disclosed
EP-0146053-B1 CHEMICAL PROCESS FOR PREPARING ANTIBIOTIC L 17392 (DEGLUCOTEICOPLANIN) AND ITS SALTS GRUPPO LEPETIT S.p.A. (IT) 1991-12-27 EP disclosed
EP-0240609-B1 ANTIBIOTIC A 40926 N-ACYLAMINOGLUCURONYL AGLYCONS AND ANTIBIOTIC A 40926 AGLYCON GRUPPO LEPETIT S.p.A. (IT) 1991-12-04 EP disclosed
EP-0406745-A1 Antibiotic GE 2270 factors A1, A2, A3 and H GRUPPO LEPETIT S.p.A. (IT) 1991-01-09 EP disclosed
US-4868171-A Antibiotic A 40926 N-acylaminoglucuronyl aglycons and antiobiotic A 40926 aglycon GRUPPO LEPETIT S.P.A. (IT) 1989-09-19 US disclosed
EP-0240609-A2 Antibiotic A 40926 N-acylaminoglucuronyl aglycons and antibiotic A 40926 aglycon GRUPPO LEPETIT S.p.A. (IT) 1987-10-14 EP disclosed
US-4629781-A STRONG ACIDOLYSIS CONTROLLED BY THE USE OF SOLVENT, ACID, CONCENTRATION AND HEATING GRUPPO LEPETIT S.P.A. (IT) 1986-12-16 US disclosed
EP-0146053-A2 Chemical process for preparing antibiotic L 17392 (Deglucoteicoplanin) and its salts GRUPPO LEPETIT S.p.A. (IT) 1985-06-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200102323-A1 ACC INHIBITORS AND USES THEREOF ACACA, ACACB, ACAT2 ALDH1A1 104/4885L3MBTL1 2864/4885MAPT 2490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.